These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27726921)

  • 1. Corrigendum to "Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival" [Gynecol. Oncol. 141 (2016) 421-427].
    Boothe D; Orton A; Odei B; Stoddard G; Suneja G; Poppe MM; L Werner T; Gaffney DK
    Gynecol Oncol; 2016 Dec; 143(3):690-691. PubMed ID: 27726921
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival.
    Boothe D; Orton A; Odei B; Stoddard G; Suneja G; Poppe MM; Werner TL; Gaffney DK
    Gynecol Oncol; 2016 Jun; 141(3):421-427. PubMed ID: 27005441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
    Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
    Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study" [Gynecol. Oncol. 151 (2018) 18-23].
    Olawaiye AB; Java JJ; Krivak TC; Friedlander M; Mutch DG; Glaser G; Geller M; O'Malley DM; Wenham RM; Lee RB; Bodurka DC; Herzog TJ; Bookman MA
    Gynecol Oncol; 2019 Jan; 152(1):220. PubMed ID: 30360899
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Adjuvant and first line chemotherapy use for endometrial cancer" [Gynecol. Oncol. Rep. 41 (2022) 101002].
    Knisely A; Huang Y; Li Y; Prabhu VS; Wright JD
    Gynecol Oncol Rep; 2023 Apr; 46():101112. PubMed ID: 37082519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center" [Gynecol. Oncol. 142 (2016) 13-18].
    Schlappe BA; Mueller JJ; Zivanovic O; Gardner GJ; Long Roche K; Sonoda Y; Chi DS; O'Cearbhaill RE
    Gynecol Oncol; 2016 Oct; 143(1):225. PubMed ID: 27496397
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to 'Tumor diameter as a predictor of lymphatic dissemination in endometrioid endometrial cancer' [Gynecol. Oncol. 141 (2016) 199-205].
    Cox Bauer CM; Greer DM; Kram JJF; Kamelle SA
    Gynecol Oncol; 2017 Mar; 144(3):649. PubMed ID: 28131527
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase 3 trial of postoperative chemotherapy alone versus chemoradiation therapy in stage III-IV gastric cancer treated with R0 gastrectomy and D2 lymph node dissection.
    Kim TH; Park SR; Ryu KW; Kim YW; Bae JM; Lee JH; Choi IJ; Kim YJ; Kim DY
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e585-92. PubMed ID: 22975616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of radiation dose and chemotherapy on overall survival in 237 patients with Stage III non-small-cell lung cancer.
    Wang L; Correa CR; Zhao L; Hayman J; Kalemkerian GP; Lyons S; Cease K; Brenner D; Kong FM
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1383-90. PubMed ID: 18929449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
    Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
    Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer.
    Wilkinson-Ryan I; Binder PS; Pourabolghasem S; Al-Hammadi N; Fuh K; Hagemann A; Thaker P; Schwarz J; Grigsby P; Mutch D; Powell M
    Gynecol Oncol; 2014 Jul; 134(1):24-8. PubMed ID: 24823648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum to "Co-existent abdominoperitoneal tuberculosis with endometrial cancer: A diagnostic and surgical challenge" [Gynecol. Oncol. Rep. 37 (2021) 100848].
    Ashraf M; Goh WA; Tan EMX; Nadarajah R
    Gynecol Oncol Rep; 2021 Nov; 38():100861. PubMed ID: 34977315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential versus "sandwich" sequencing of adjuvant chemoradiation for the treatment of stage III uterine endometrioid adenocarcinoma.
    Lu SM; Chang-Halpenny C; Hwang-Graziano J
    Gynecol Oncol; 2015 Apr; 137(1):28-33. PubMed ID: 25666606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG).
    Leong T; Smithers BM; Michael M; Gebski V; Boussioutas A; Miller D; Simes J; Zalcberg J; Haustermans K; Lordick F; Schuhmacher C; Swallow C; Darling G; Wong R
    BMC Cancer; 2015 Jul; 15():532. PubMed ID: 26194186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to "Phase III trials in ovarian cancer: The evolving landscape of front line therapy" [Gynecol. Oncol. 153 (2019) 436-444].
    Naumann RW; Coleman RL; Brown J; Moore KN
    Gynecol Oncol; 2020 Feb; 156(2):512-513. PubMed ID: 31859001
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to 'Treatment outcomes in patients with FIGO stage IB-IIA cervical cancer and a focally disrupted cervical stromal ring on magnetic resonance imaging: A propensity score matching study' [Gynecol. Oncol. 143 (2016) 77-82].
    Kong TW; Lee JD; Son JH; Paek J; Chun M; Chang SJ; Ryu HS
    Gynecol Oncol; 2017 Jan; 144(1):228. PubMed ID: 27890281
    [No Abstract]   [Full Text] [Related]  

  • 17. Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer.
    Milgrom SA; Kollmeier MA; Abu-Rustum NR; Tew WP; Sonoda Y; Barakat RR; Alektiar KM
    Gynecol Oncol; 2013 Sep; 130(3):436-40. PubMed ID: 23800696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population.
    Dobie SA; Warren JL; Matthews B; Schwartz D; Baldwin LM; Billingsley K
    Cancer; 2008 Feb; 112(4):789-99. PubMed ID: 18189291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors of stage III endometrial carcinoma].
    Li J; Kong WM
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(3):198-200. PubMed ID: 19537039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum to "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)" [Gynecol. Oncol. Rep. 31 (2020) 100532].
    Santin AD; Filiaci V; Bellone S; O'Cearbhaill R; Ratner ES; Mathews CA; Cantuaria G; Gunderson CC; Rutledge T; Buttin BM; Lankes HA; Birrer MJ
    Gynecol Oncol Rep; 2020 Aug; 33():100590. PubMed ID: 32885014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.